Targeting resistance mechanisms in SMARCB1-deficient tumors

Ended Project Grant Awarded Last action

Award ID
W81XWH2110951
Recipient
Awarding agency
Obligated
$456,662

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Texas MD Anderson Cancer Center received a $456,662 Project Grant award from the Department of the Army Medical Command on September 30, 2021 to fund research targeting resistance mechanisms in SMARCB1-deficient tumors. The grant is part of the Military Medical Research and Development program administered by the Department of Defense under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and cancer research. Specifically, the MD Anderson Cancer Center will investigate medical solutions for SMARCB1-deficient tumors through basic, applied, and advanced research efforts funded by this award through September 29, 2024. The grant aims to develop new treatment approaches for this type of cancer.

Quick answers

Who received award W81XWH2110951?

W81XWH2110951 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on September 30, 2021.

How much is award W81XWH2110951 worth?

$456,662 has been obligated on W81XWH2110951.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login